Mesoblast Limited (Premium)



Ticker code: MSB

MSB Red Flags & Risk Indicators
⚠️ RED FLAGS: 5 identified

  • Negative Operating Cash Flow
  • Low Operating Margin
  • Highly Shorted
  • Increasing Shorts
  • High Price to Book vs ROE

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.00762 0.02178 0.11063 185.6 408.1 -0.07811 -0.08674 0.00394 -11.0 104.5
MSB Revenue Per Share (2012–2027)
✅✅
Mesoblast Limited (MSB) Revenue Chart 2012–2027
MSB Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Mesoblast Limited (MSB) EBITDA Chart 2012–2027
MSB Normalised Earnings Per Share (EPS) (2012–2027)
✅✅
Mesoblast Limited (MSB) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
191.7 5.5 -6.9 -21.4 None -42.8 None -64.2 11/10/25
MSB Yearly Price Earnings Ratio (PER) Highs and Lows

Mesoblast Limited (MSB) PER Highs and Lows (2012–2027)
MSB Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Mesoblast Limited (MSB) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *